Provided by Tiger Trade Technology Pte. Ltd.

LEPU BIO-B

5.280
+0.1603.13%
Volume:9.04M
Turnover:47.39M
Market Cap:9.53B
PE:-21.70
High:5.360
Open:5.240
Low:5.070
Close:5.120
52wk High:10.500
52wk Low:3.050
Shares:1.80B
HK Float Shares:1.80B
Volume Ratio:0.54
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.243
ROE:-24.53%
ROA:-3.93%
PB:11.25
PE(LYR):-21.70
PS:11.97

Loading ...

Assessing Lepu Biopharma (SEHK:2157) Valuation After New 2025 Profit Guidance And Dividend Discussion

Simply Wall St.
·
Mar 15

LEPU BIO-B (02157) Sets 25 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal

Bulletin Express
·
Mar 11

Lepu Biopharma Says AstraZeneca Begins Phase 3 Trial of CMG901 Cancer Therapy; Shares Jump 7%

MT Newswires Live
·
Mar 11

AstraZeneca Pays $45 Million Milestone Fee to LEPU BIO-B

Stock News
·
Mar 11

LEPU BIO-B Issues Positive Profit Alert, Anticipates Net Profit Attributable to Owners of No Less Than RMB 200 Million

Stock News
·
Mar 11

Lepu Biopharma forecasts FY2025 net profit attributable to shareholders of at least RMB200 million

Reuters
·
Mar 11

Lepu Biopharma Co - Expected Result Due to Revenue Increase From Puyouheng and Meiyouheng After Nmpa Approval in October 2025, Others in FY

THOMSON REUTERS
·
Mar 11

Lepu Biopharma - Expects FY Net Profit Attributable of at Least RMB200 Mln

THOMSON REUTERS
·
Mar 11

Keymed Biosciences receives USD45 million CMG901 milestone payment from AstraZeneca

Reuters
·
Mar 10

LEPU BIO-B Shares Surge Over 6% in Afternoon Trading on IND Approval for MRG006A Combination Therapy

Stock News
·
Mar 06

LEPU BIO-B (02157) Announces February 2026 Equity Status with No Change in Share Capital

Bulletin Express
·
Mar 05

Lepu Biopharma Co., Ltd.'s (HKG:2157) Low P/S No Reason For Excitement

Simply Wall St.
·
Feb 11

Lepu Biopharma (02157) Releases Monthly Return Showing Unchanged Share Capital

Bulletin Express
·
Feb 05

HK Movers | Innovative Drug Stocks Jump With TYK Medicines up 14%

Tiger Newspress
·
Jan 07

Lepu Biopharma Announces Licensing Transaction Update

Reuters
·
Dec 18, 2025

Lepu Biopharma Co. Ltd. held second extraordinary general meeting

Reuters
·
Dec 18, 2025

HKD 360 Billion Wiped Out! "Consumer Trio" Plunges Sharply

Deep News
·
Dec 09, 2025

Lepu Biopharma (SEHK:2157): Valuation Check After New GLP-1 CDMO Framework Deal With Lepu Medical

Simply Wall St.
·
Dec 05, 2025

Lepu Biopharma (02157) Reports Unchanged Share Capital for November 2025

Bulletin Express
·
Dec 04, 2025

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Stock News
·
Dec 03, 2025